Addiciton

Model Identifies Adolescents at Risk for Smoking Initiation

Model Identifies Adolescents at Risk for Smoking Initiation

A novel prognostic tool can be used to accurately identify adolescents at risk for initiating cigarette smoking.

Therapy Focusing on Mindfulness Improves Outcomes for Women With Substance Use Disorder

Therapy Focusing on Mindfulness Improves Outcomes for Women With Substance Use Disorder

By

These findings are consistent with emerging neurocognitive models linking interoception to emotion regulation and related health outcomes, providing valuable input in improving substance use disorder treatment.

Public Support Only Moderate for Opioid Harm Reduction Strategies

Public Support Only Moderate for Opioid Harm Reduction Strategies

Stigmatizing attitudes toward those who use opioids are associated with lower support for two evidence-based opioid harm reduction strategies.

Association Between Industry Payments and Opioid Prescribing

Association Between Industry Payments and Opioid Prescribing

By

Non-research industry payments to physicians may be associated with increases in opioid prescribing rates.

Alcohol Use Disorder Registration Impacts Risk for Spouse

Alcohol Use Disorder Registration Impacts Risk for Spouse

Among married individuals, first alcohol use disorder registration in national medical registries is associated with an increased risk of first alcohol use disorder registration in the spouse.

Examining Rates of Long-Term Opioid Use in Youth With Psychiatric Disorders

Examining Rates of Long-Term Opioid Use in Youth With Psychiatric Disorders

By

Adolescents with anxiety, mood, neurodevelopmental, sleep, and nonopioid substance use disorders and most mental health treatments were significantly more likely to receive opioids.

New APA Guideline Recommendation for Treatment of Alcohol Use Disorder

New APA Guideline Recommendation for Treatment of Alcohol Use Disorder

By

The new guideline focuses on evidence-based pharmacologic treatments in alcohol use disorder and includes recommendations about naltrexone, acamprosate, disulfiram, topiramate, and gabapentin.

Sign Up for Free e-newsletters